Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial.
van Esch HJ, van Zuylen L, Geijteman ECT, Oomen-de Hoop E, Huisman BAA, Noordzij-Nooteboom HS, Boogaard R, van der Heide A, van der Rijt CCD. van Esch HJ, et al. Among authors: noordzij nooteboom hs. JAMA. 2021 Oct 5;326(13):1268-1276. doi: 10.1001/jama.2021.14785. JAMA. 2021. PMID: 34609452 Free PMC article. Clinical Trial.
COVID-19 vaccination in patients with immune thrombocytopenia.
Visser C, Swinkels M, van Werkhoven ED, Croles FN, Noordzij-Nooteboom HS, Eefting M, Last-Koopmans SM, Idink C, Westerweel PE, Santbergen B, Jobse PA, Baboe F; RECOVAC-IR Consortium; Te Boekhorst PAW, Leebeek FWG, Levin MD, Kruip MJHA, Jansen AJG. Visser C, et al. Among authors: noordzij nooteboom hs. Blood Adv. 2022 Mar 22;6(6):1637-1644. doi: 10.1182/bloodadvances.2021006379. Blood Adv. 2022. PMID: 34941989 Free PMC article.
Understanding what matters most to patients in acute care in seven countries, using the flash mob study design.
van den Ende ES, Schouten B, Kremers MNT, Cooksley T, Subbe CP, Weichert I, van Galen LS, Haak HR, Kellett J, Alsma J, Siegrist V, Holland M, Christensen EF, Graham CA, Leung LY, Laugesen LE, Merten H, Mir F, Kidney RM, Brabrand M, Nanayakkara PWB, Nickel CH; all local collaborators. van den Ende ES, et al. BMC Health Serv Res. 2021 May 19;21(1):474. doi: 10.1186/s12913-021-06459-4. BMC Health Serv Res. 2021. PMID: 34011321 Free PMC article.
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.
van de Loosdrecht AA, Cremers EMP, Alhan C, Duetz C, In 't Hout FEM, Visser-Wisselaar HA, Chitu DA, Verbrugge A, Cunha SM, Ossenkoppele GJ, Janssen JJWM, Klein SK, Vellenga E, Huls GA, Muus P, Langemeijer SMC, de Greef GE, Te Boekhorst PAW, Raaijmakers MHG, van Marwijk Kooy M, Legdeur MC, Wegman JJ, Deenik W, de Weerdt O, van Maanen-Lamme TM, Jobse P, van Kampen RJW, Beeker A, Wijermans PW, Biemond BJ, Tanis BC, van Esser JWJ, Schaar CG, Noordzij-Nooteboom HS, Jacobs EMG, de Graaf AO, Jongen-Lavrencic M, Stevens-Kroef MJPL, Westers TM, Jansen JH. van de Loosdrecht AA, et al. Among authors: noordzij nooteboom hs. Leukemia. 2024 Apr;38(4):840-850. doi: 10.1038/s41375-024-02161-6. Epub 2024 Jan 31. Leukemia. 2024. PMID: 38297135 Free PMC article. Clinical Trial.